Back to search

Article

Mutational footprint of platinum chemotherapy in a secondary thyroid cancer

2022-03-15

Abstract excerpt

Although papillary thyroid carcinoma (PTC) is the most frequent endocrine tumor with a generally excellent prognosis, a patient developed a clinically aggressive PTC eleven years after receiving platinum chemotherapy for ovarian endometrioid adenocarcinoma. Germline and somatic analyses of multi-temporal and multi-regional molecular profiles indicated that ovarian and thyroid tumors did not share common genetic al...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b5afe31-55a6-59fd-a78a-4652e3d6f9c6
DOI
10.1101/2022.03.14.484002
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutational footprint of platinum chemotherapy in a secondary thyroid cancerDOI 10.1101/2022.03.14.484002
Select a neighboring publication to make it the new centre.